Different patterns of disease manifestations of parvovirus B19-associated reactive juvenile arthritis and the induction of antiphospholipid-antibodies

Clinical Rheumatology

Volumn 27, Issue 3, 2008, Pages 333-338

  Lehmann, Hartwig W ^a   Plentz, Annelie ^b   Von Landenberg, Philipp ^c   Küster, Rolf M ^d   Modrow, Susanne ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d Center of Pediatric Rheumatology   (Germany)

Author keywords

Antiphospholipid antibodies; Juvenile arthritis; Parvovirus B19; Persistent infection

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; CYCLOSPORIN A; DOUBLE STRANDED DNA ANTIBODY; GLUCOCORTICOID; IMMUNOGLOBULIN G; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; NONSTRUCTURAL PROTEIN 1; PHOSPHOLIPID ANTIBODY; PREDNISOLONE; PROTEIN VP1; PROTEIN VP2; RHEUMATOID FACTOR; STEROID; VIRUS DNA; VIRUS PROTEIN; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; APPENDECTOMY; APPENDICITIS; ARTHRALGIA; ARTICLE; CHILD; CLINICAL ARTICLE; COLITIS; DISEASE COURSE; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTHESITIS; ERYTHEMA INFECTIOSUM; FEMALE; HASHIMOTO DISEASE; HORMONE SUBSTITUTION; HUMAN; IONTOPHORESIS; JUVENILE RHEUMATOID ARTHRITIS; ONSET AGE; PARVOVIRUS; PARVOVIRUS INFECTION; POLYARTHRITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; RELAPSE; REMISSION; SCHOOL CHILD; SPONDYLOLISTHESIS; UNSPECIFIED SIDE EFFECT; UVEITIS; VIREMIA; VIRUS LOAD; ARTHRITIS; BLOOD; CASE REPORT; IMMUNOLOGY; VIROLOGY; VIRUS INFECTION;

ADOLESCENT; ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ARTHRITIS; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN;

EID: 41949091327     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0718-7     Document Type: Article

References (14)

1. ED Heegaard KE Brown 2002 Human parvovirus B19 Clin Microbiol Rev 15 485 505 12097253 10.1128/CMR.15.3.485-505.2002 (Pubitemid 34761354)
2. Kerr JR, Modrow S (2006) Human and primate erythrovirus infections and associated disease. In: Berns KI (ed) Parvoviruses. Hodder Arnold, London, Great Britain, pp 385-416
3. HW Lehmann L Kühner K Beckenlehner E Müller-Godeffroy KG Heide RM Küster S Modrow 2002 Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence J Clin Virol 25 135 143 12367647 10.1016/S1386-6532(01)00247-5 1:CAS:528:DC%2BD38XnsVagtbo%3D (Pubitemid 35287237)
4. HW Lehmann A Knöll R-M Küster S Modrow 2003 Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood Arthritis Rheum 48 1631 1638 12794831 10.1002/art.10979 (Pubitemid 36682371)
5. JJ Nocton LC Miller LB Tucker JG Schaller 1993 Human parvovirus B19-associated arthritis in children J Pediat 122 186 90 8429430 10.1016/S0022-3476(06)80111-3 1:STN:280:ByyC2Mrot1E%3D
6. F Oguz C Akdeniz E Ünüvar Ö Kücükbasmaci M Sidal 2002 Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritis J Paediatr Child Health 38 358 362 12173996 10.1046/j.1440-1754.2002. 00789.x 1:STN:280:DC%2BD38vhvFOmsw%3D%3D (Pubitemid 35024975)
7. P von Landenberg HW Lehmann A Knöll S Dorsch S Modrow 2003 Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection Arthritis Rheum 48 1939 1947 10.1002/art.11038 (Pubitemid 36828689)
8. L Liefeldt A Plentz B Klempa O Kershaw AS Endres U Raab HH Neumayer H Meisel S Modrow 2005 Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simulataneous detection of genotypes 1 to 3 J Med Virol 75 161 169 15543575 10.1002/jmv.20251 1:CAS:528:DC%2BD2MXhs1Ghug%3D%3D (Pubitemid 39578804)
9. M Söderlund R von Essen J Haapasaari U Kiistala O Kiviluoto K Hedman 1997 Persistence of parvovirus B19 DNA in young patients with and without chronic arthropathy The Lancet 349 1063 1065 10.1016/S0140-6736(96)09110-6 (Pubitemid 27158252)
10. P Cassinotti G Siegel 1997 Quantitative evidence for persistence of human parvovirus B19 DNA in an immunocompetent individual Eur J Clin Microbiol Infect Dis 19 886 887 10.1007/s100960000384
11. P Norja K Hokynar LM Aaltonen R Chen A Ranki EK Partio O Kiviluoto I Davidkin T Leivo AM Eis-Hübinger B Schneider HP Fischer R Tolba O Vapalahti A Vaheri M Söderlund-Vernermo K Hedman 2006 Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue PNAS 103 7450 7453 16651522 10.1073/pnas.0602259103 1:CAS:528: DC%2BD28XkslOrt7k%3D (Pubitemid 43727853)
12. SA Oliveira LA Camacho AC Pereira TF Faillace S Setubal JP Nascimento 2002 Clinical and epidemiological aspects of human parvovirus B19 infection in an urban area in Brazil Mem Inst Oswaldo Crus 97 965 970
13. L Harel R Straussberg H Rudlich AH Cohen J Amir 2000 Raynaud's phenomenon as a manifestation of parvovirus B19 infection: case reports and review of parvovirus B19 rheumatic and vasculitic syndromes Clin Infect Dis 30 500 503 10722434 10.1086/313712 1:STN:280:DC%2BD3c7oslagug%3D%3D (Pubitemid 30205295)
14. S Dorsch G Liebisch B Kaufmann P von Landenberg JH Hoffmann W Drobnik S Modrow 2002 The VP1 unique region of parvovirus B19 and its constitutent phospholipase A2-like activity J Virol 76 2014 2018 11799199 10.1128/JVI.76.4.2014-2018.2002 1:CAS:528:DC%2BD38XnvF2isw%3D%3D (Pubitemid 34094651)